850 related articles for article (PubMed ID: 18755179)
1. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
McDonald HA; Neelands TR; Kort M; Han P; Vos MH; Faltynek CR; Moreland RB; Puttfarcken PS
Eur J Pharmacol; 2008 Oct; 596(1-3):62-9. PubMed ID: 18755179
[TBL] [Abstract][Full Text] [Related]
2. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid.
El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819
[TBL] [Abstract][Full Text] [Related]
3. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1.
Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S
Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992
[TBL] [Abstract][Full Text] [Related]
5. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
[TBL] [Abstract][Full Text] [Related]
6. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord.
Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS
Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316
[TBL] [Abstract][Full Text] [Related]
7. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
[TBL] [Abstract][Full Text] [Related]
8. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
9. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin differentially modulates voltage-activated calcium channel currents in dorsal root ganglion neurones of rats.
Hagenacker T; Splettstoesser F; Greffrath W; Treede RD; Büsselberg D
Brain Res; 2005 Nov; 1062(1-2):74-85. PubMed ID: 16269136
[TBL] [Abstract][Full Text] [Related]
11. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists.
Appendino G; Harrison S; De Petrocellis L; Daddario N; Bianchi F; Schiano Moriello A; Trevisani M; Benvenuti F; Geppetti P; Di Marzo V
Br J Pharmacol; 2003 Aug; 139(8):1417-24. PubMed ID: 12922928
[TBL] [Abstract][Full Text] [Related]
12. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.
Spicarova D; Palecek J
J Neurophysiol; 2009 Jul; 102(1):234-43. PubMed ID: 19369364
[TBL] [Abstract][Full Text] [Related]
13. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons.
Wu ZZ; Chen SR; Pan HL
Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970
[TBL] [Abstract][Full Text] [Related]
14. Systemic and site-specific effects of A-425619, a selective TRPV1 receptor antagonist, on wide dynamic range neurons in CFA-treated and uninjured rats.
McGaraughty S; Chu KL; Faltynek CR; Jarvis MF
J Neurophysiol; 2006 Jan; 95(1):18-25. PubMed ID: 16162831
[TBL] [Abstract][Full Text] [Related]
15. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin.
Kanai Y; Hara T; Imai A
J Pharm Pharmacol; 2006 Apr; 58(4):489-93. PubMed ID: 16597366
[TBL] [Abstract][Full Text] [Related]
16. Effects of capsaicin on Ca(2+) release from the intracellular Ca(2+) stores in the dorsal root ganglion cells of adult rats.
Eun SY; Jung SJ; Park YK; Kwak J; Kim SJ; Kim J
Biochem Biophys Res Commun; 2001 Aug; 285(5):1114-20. PubMed ID: 11478769
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat.
Jakab B; Helyes Z; Varga A; Bölcskei K; Szabó A; Sándor K; Elekes K; Börzsei R; Keszthelyi D; Pintér E; Petho G; Németh J; Szolcsányi J
Eur J Pharmacol; 2005 Jul; 517(1-2):35-44. PubMed ID: 15978575
[TBL] [Abstract][Full Text] [Related]
18. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818
[TBL] [Abstract][Full Text] [Related]
19. Intracellular acidification evoked by moderate extracellular acidosis attenuates transient receptor potential V1 (TRPV1) channel activity in rat dorsal root ganglion neurons.
Chung S; Kim YH; Koh JY; Nam TS; Ahn DS
Exp Physiol; 2011 Dec; 96(12):1270-81. PubMed ID: 21930676
[TBL] [Abstract][Full Text] [Related]
20. Contribution of transient receptor potential vanilloid subtype 1 to the analgesic and antihyperalgesic activity of nefopam in rodents.
Verleye M; Gillardin JM
Pharmacology; 2009; 83(2):116-21. PubMed ID: 19096234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
